MedTrace Logo

The Scandinavian AED and Mobile Bystander Activation Trial

NCT02992873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 815

Last updated 2020-11-24

No results posted yet for this study

Summary

Sudden cardiac death is a major health problem in the western world. In Europe alone nearly 300 000 patients are affected annually. The majority of victims suffering from an Out-of-Hospital Cardiac Arrest (OHCA have an initial cardiac rhythm that can be treated by means of defibrillation. In most emergency medical systems (EMS) time to defibrillation is too long and survival averages 10 %.However, when laymen operated Automated External Defibrillators (AEDs) are used within the first minutes, 7 out of 10 may survive.

The aim of "The Scandinavian AED and Mobile Bystander Activation" (SAMBA) trial is to evaluate if a Mobile Phone Positioning system and a smartphone application will increase the proportions of patients with an attached Automated External Defibrillator (AED) before arrival of the Emergence Medical System (EMS). Mobile phone technology and a smartphone application will be used identify and recruit nearby CPR-trained lay people and automated external defibrillators (AEDs) to patients suffering out-of-hospital cardiac arrest (OHCA). The system is currently running in Stockholm Sweden and in the Gothenburg region.

Conditions

  • Out-Of-Hospital Cardiac Arrest
  • Cardiac Arrest, Sudden

Interventions

DEVICE

Layperson allocated to start CPR and fetch nearest AED

Dispatching laypersons to fetch an AED and start CPR in out-of-hospital cardiac arrest

DEVICE

Layperson allocated to start CPR

Dispatching laypersons to start CPR out-of-hospital cardiac arrest

Sponsors & Collaborators

Principal Investigators

  • Mattias Ringh, MD, PhD · Karolinska Institutet

  • Jacob Hollenberg, MD, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2020-10-20
Completion
2020-10-20

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02992873 on ClinicalTrials.gov